Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects

Launched by NATIONAL INSTITUTE OF RESPIRATORY DISEASES, MEXICO · Feb 2, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effectiveness of a combined approach to help people quit smoking while they are hospitalized. Tobacco use is a major health issue, responsible for millions of deaths each year, and many patients who are in the hospital are still active smokers. The goal of this study is to see if a standardized treatment plan can help these individuals successfully stop smoking and stay smoke-free even after they leave the hospital.

To participate in this trial, you need to be at least 18 years old, currently smoking cigarettes, and admitted to the hospital. The study is looking for people who have smoked more than 100 cigarettes in their lifetime and have smoked in the last month. If you've recently used medications to help quit smoking or have certain health conditions that prevent you from taking specific treatments, you may not be eligible. Participants will receive a combination of treatments and support to help them quit smoking during their hospital stay. This study aims to find a more effective way to support smokers in their journey to quit and improve their health.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • \>18 years Active smokers (consumption of more than 100 cigarettes in their entire life, and who have consumed cigarettes in the last 30 days) Hospitalized subjects Informed consent
• Exclusion Criteria:
• • Subjects who have had pharmacological treatment to stop smoking in the last month
• • Subjects with contraindications for medications.
• • Sample size calculation, 80% power, unilateral, due to difference in proportions, estimated loss of 25%.